We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
TriLink Announces Sales and License Agreement with Glen Research for CleanAmp™ Amidites
News

TriLink Announces Sales and License Agreement with Glen Research for CleanAmp™ Amidites

TriLink Announces Sales and License Agreement with Glen Research for CleanAmp™ Amidites
News

TriLink Announces Sales and License Agreement with Glen Research for CleanAmp™ Amidites

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "TriLink Announces Sales and License Agreement with Glen Research for CleanAmp™ Amidites"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

TriLink BioTechnologies (TriLink), announced that it has signed a sales and license agreement with Glen Research Corporation to sell TriLink's CleanAmp™ Amidites.

Glen Research can now sell the patented CleanAmp™ Amidites produced by TriLink to third parties for use in the production of CleanAmp™ Primers.

TriLink's CleanAmp™ technology offers a less expensive approach to high stringency PCR. CleanAmp™ is a unique solution, where the primer or dNTP components of the PCR reaction mix, rather than the enzymes are modified.

Making the CleanAmp™ Amidites available through Glen Research allows institutions with oligonucleotide synthesis capabilities to manufacture CleanAmp™ Primers in-house.

"Glen Research is dedicated to bringing the very best research products to the oligonucleotide synthesis market. So we are delighted to be able to offer CleanAmp™ Amidites in partnership with TriLink. We feel that the CleanAmp™ Amidites will make an excellent addition to our repertoire of products for DNA research," said Glen Research President/CEO, Dr. Hugh Mackie.

"TriLink and Glen Research have a long standing relationship built on a shared interest in advancing science through the highest quality reagents and technical expertise. We feel Glen Research is the perfect partner for bringing CleanAmp™ Amidites to the marketplace," said TriLink CEO, Dr. Richard Hogrefe.

Advertisement